Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer-Reference-Cited by-同舟云学术

Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer

Published:2017-11-23 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zacharias Niki Marie,McCullough Christopher,Shanmugavelandy Sriram,Lee Jaehyuk,Lee Youngbok,Dutta Prasanta,McHenry James,Nguyen Linda,Norton William,Jones Lawrence W.,Bhattacharya Pratip K.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-16327-z.pdf

Reference56 articles.

1. Cookson, M. S. et al. Castration-resistant prostate cancer: AUA Guideline. The Journal of urology 190, 429–438 (2013).

2. de Bono, J. S. et al. Abiraterone and increased survival in metastatic prostate cancer. The New England journal of medicine 364, 1995–2005 (2011).

3. Ryan, C. J. et al. Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response. Clinical cancer research: an official journal of the American Association for Cancer Research 17, 4854–4861 (2011).

4. Efstathiou, E. et al. Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 30, 637–643, https://doi.org/10.1200/JCO.2010.33.7675 (2012).

5. Chen, E. J. et al. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clinical cancer research: an official journal of the American Association for Cancer Research 21, 1273–1280, https://doi.org/10.1158/1078-0432.CCR-14-1220 (2015).

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamine Metabolism and Prostate Cancer;Cancers;2024-08-18

2. Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer;Oncogene;2024-05-15

3. METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression;Signal Transduction and Targeted Therapy;2024-04-17

4. Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection;Nature Structural & Molecular Biology;2023-10-19

5. Metabolic Alterations in Canine Mammary Tumors;Animals;2023-08-30